AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 83 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,000 | -66.7% | 15,181 | -24.6% | 0.00% | – |
| Q1 2022 | $9,000 | -18.2% | 20,123 | 0.0% | 0.00% | – |
| Q4 2021 | $11,000 | -66.7% | 20,123 | 0.0% | 0.00% | – |
| Q3 2021 | $33,000 | -2.9% | 20,123 | 0.0% | 0.00% | – |
| Q2 2021 | $34,000 | +580.0% | 20,123 | +70.5% | 0.00% | – |
| Q2 2019 | $5,000 | -28.6% | 11,799 | 0.0% | 0.00% | – |
| Q1 2019 | $7,000 | +40.0% | 11,799 | 0.0% | 0.00% | – |
| Q4 2018 | $5,000 | -16.7% | 11,799 | 0.0% | 0.00% | – |
| Q3 2018 | $6,000 | -76.9% | 11,799 | 0.0% | 0.00% | – |
| Q2 2018 | $26,000 | -84.7% | 11,799 | -96.4% | 0.00% | – |
| Q2 2017 | $170,000 | +4150.0% | 326,224 | +6345.8% | 0.00% | – |
| Q1 2017 | $4,000 | -20.0% | 5,061 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | -91.7% | 5,061 | -37.1% | 0.00% | – |
| Q1 2015 | $60,000 | +122.2% | 8,050 | 0.0% | 0.00% | – |
| Q4 2014 | $27,000 | -6.9% | 8,050 | 0.0% | 0.00% | – |
| Q3 2014 | $29,000 | – | 8,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,595,484 | $10,564,000 | 9.31% |
| Cypress Capital Management LLC (WY) | 108,400 | $441,000 | 0.50% |
| Noven Financial Group, Inc. | 158,059 | $643,000 | 0.37% |
| Transform Wealth, LLC | 205,481 | $836,000 | 0.15% |
| GHP Investment Advisors, Inc. | 100,000 | $407,000 | 0.06% |
| Pratt Collard Advisory Partners LLC | 15,600 | $63,000 | 0.05% |
| JANICZEK WEALTH MANAGEMENT, LLC | 16,719 | $68,000 | 0.04% |
| Virtu Financial LLC | 92,344 | $376,000 | 0.02% |
| JFS WEALTH ADVISORS, LLC | 18,150 | $74,000 | 0.02% |
| CONDOR CAPITAL MANAGEMENT | 21,400 | $87,000 | 0.02% |